In the preliminary report from 2013 on NCT01044069, in which adult patients with relapsed B-ALL received CAR T cells targeting CD19 with a CD28 costimulatory domain, Brentjens et al. reported on the first 5 patients. Here, CD19 is linked to acute lymphoblastic leukemia.